Shedding its gains from Monday, NIkkei has declined around 0.7% while Hang Seng and Shanghai Composite were trading marginally lower.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
Pharma major Sun Pharma remained the worst loser in the Sensex pack for the second day in a row after reports that regulator Sebi may reopen the insider trading case against the company.
Investors took the Yes Bank event negatively because it raises a question on the stability of the overall Indian financial system.
Among key stocks, Tata Motors, Hero MotoCorp, L&T, Wipro, ICICI Bank, Dr Reddy's Labs and ICICI Bank, all up between 1%-3%
The 30-share Sensex ended down 297 points at 27,438 and the 50-share Nifty closed 93 points lower at 8,305.
The broader Nifty, after touching a high (intra-day) of 10,555.50 points, finished at 10,539.75, up 84.80 points, or 0.81 per cent.
If Jatin Singh is right in the long run and his morphed business can help reduce farmer distress, Skymet will provide a service of far more value from where it began
The market breadth in BSE remains positive with 1,554 shares advancing and 1,196 shares declining.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Persistent capital inflows by domestic institutional investors and retail investors kept the markets in fine nick
JLR is the UK's largest carmaker, which has witnessed a complete turnaround in its fortunes since Tata Motors acquired the traditional British brands from Ford 10 years ago.
Sensex, Nifty put up a good show in closing trade.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
The 30-share Sensex is down 359 points at 26,378 and the Nifty has dropped 78 points to trade at 7,883
FIIs pump in Rs 2,075 crore in past three trading sessions.
Broader markets broke the winning streak and ended lower, underperforming the benchmark indices
Sensex surged 486 points or 1.9%.
The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.
With average capacity utilisation now touching 76 per cent, Indian companies are going back to the drawing board to add capacity but the plans to build new factories and plants are still some months away.
The index had risen over 585 points in the previous three sessions.
Benchmark share indices opened lower on Monday, amid weak global cues, as investors turned cautious ahead of the US Federal Reserve stance on interest rate.
Construction major L&T was the biggest gainer among the Sensex components, spurting 2.30 per cent, after the company said its board has approved a Rs 9,000-crore share buyback plan.
Adani Enterprises plans to invest a total of $25 billion in the next five years.
The sentiment got support from better-than-expected earning results by select companies and continuous buying by domestic financial institutions.
Broader markets outperformed with BSE Midcap and BSE Smallcap adding 0.23% and 0.45%, respectively
the Sensex lost 23 points to close at 28,185 levels and the Nifty shed 7 points to end at 8,515 mark.
Following the October 24 Supreme Court order, the department of telecom estimated that the total liability of 15 telecom companies, including penalties and interest, would be Rs 1.47 lakh crore.
The Directorate of Revenue Intelligence (DRI) has slapped a Rs 5,500-crore show-cause notice on Adani group for alleged over-valuation of capital equipment imports.
Will private firms really boost Make in India in the defence sector? Ajai Shukla seeks answers.
The 30-share Sensex ended down 39 points at 26,265 and the 50-share Nifty ended down 1 point at 7,954.
The broader NSE Nifty, after shuttling between 10,651.60 and 10.532.70 points on alternate bouts of buying and selling, closed 6.20 points, or 0.06 per cent, down at 10,576.30.
Rebound in IT majors TCS and Infosys in late trades helped markets end higher.
Infosys, TCS, HUL and Reliance Industries were the top gainers of the day.
The BSE Midcap and Smallcap indices have performed better than the front-liners
Both benchmark indices were driven by strong gains in IT, teck, oil and gas, pharma and banking shares amid earnings optimism.
Sun Pharma was the biggest gainer in the Sensex pack, advancing 1.79 per cent.
For the seven months since February 2014, the benchmark index surged nearly 27%.
Sentiment was hurt after market regulator Sebi directed bourses to initiate action against 331 suspected shell companies.